Chemistry: analytical and immunological testing – Heterocyclic carbon compound – Hetero-n
Patent
1994-02-16
1996-05-14
Redding, David A.
Chemistry: analytical and immunological testing
Heterocyclic carbon compound
Hetero-n
436 97, 436 98, 436811, G01N 3300
Patent
active
055166997
ABSTRACT:
A method of diagnosing severity of periodontal disease or peri-implant disease in a human patient, involving a) obtaining a sample of tissue or gingival crevicular or other fluid from the mouth of said patient, or a blood or urine sample from the patient, and b) measuring a pyridinoline crosslinked compound in the sample as a measure of severity of disease.
REFERENCES:
Gertz et al., J. Bone Miner. Res. 9:135-142 (1994).
Giannobile et al., J. Periodont. 64:186-190 (1993).
Risteli et al., Clin. Chem 39:635-640 (1993).
Seyedin et al., J. Bone Miner. Res. 8:635-641 (1993).
Eriksen et al., J. Bone Miner. Res. 8:127-132 (1993).
Elomaa et al., Br. J. Cancer 66:337-341 (1992).
Kunimatsu et al., J. Periodont. Res. 25:69-73 (1990).
Cox and Eley, J. Periodont. Res. 24:353-361 (1989).
Beighton and Life, Archs. Oral Biol. 34:8430846 (1989).
Cox and Eley, J. Periodont. Res. 24:41-44 (1989).
Jeffcoat et al., Adv. Dent. Res. 1:80-84 (1987).
Binder et al., J. Periodont. Res. 22:14-19 (1987).
Bowers et al., J. Periodontol 60:448-451 (1987).
Kryshtalskyj et al., J. Periodont. Res. 22:264-269 (1987).
Lamster et al., J. Periodont. 56:139-147 (1985).
Black D. et al.; "Quantitiative Analysis of the Pryridinium Crosslinks of Collagen in Urine Using Ion-paired Reversed-Phase High Performance Liquid Chromatography"; Anal. Biochem. 169:197-203 (1989).
Fujimoto D. et al.; "Analysis of Pyridinoline, A Cross-Linking Compound of Collagen Fibers, in Human Urine"; J. Biochem. 94:1133-1136 (1983).
Gunja-Smith Z. et al.; "Collagen Cross-Lining Compounds in Human Urine"; Biochem J. 197:759-762 (1981).
Haffajee A. D. et al.; "Clinical Risk Indicators for Periodontal Attachment Loss"; J. Clin. Periodontol 18:117-125 (1991).
Hanson D. A. et al.; "A Specific Immunoassay for Monitoring Human Bone Resorption:Quantitation of Type I Collagen Cross-Linked N-Telopeptides in Urine"; J. Bone and Mineral Research 7:1251-1258 (1992).
Hassager C. et al.; "Diurnal Variation in Serum Markers of Type I Collagen Synthesis and Degradation in Healthy Premenopausal Women"; J. Bone and Mineral Research 7:1307-1311 (1992).
Robins S. P. et al.; "Measurement of the Cross-Linking Compound, Pyridinoline, in Urine as an Index of Collaen Degradation in Joint Disease"Ann Rheum Dis. 46:969-973 (1986).
Rosen H. N. et al.; "Specificity of Urinary Excretion of Cross-Linked N-Telopeptides of Type I Collagen as a Marker of Bone Turnover"; Calcif. Tissue Int. 54:26-29 (1994).
Seibel M. J. et al.; "Urinary Hydroxy-pryidinium Cross Links Provide Indices of Cartliage and Bone Involvement in Arthritic Diseases"; J. Rheumatol 16:7:964-970 (1989).
Uebelhart D. et al.; "Effect of Menopause and Hormone Replacement Therapy on the Urinary Excretion of Pyridinium Cross-Links"; J. Clin. Endocrinol. Metab. 72:367-373 (1991).
Uebelhart D. et al.; "Urinary Excretion of Pyridinium Crosslinks: A New Marker of Bone Resorption in Metabolic Bone Disease"; Bone and Mineral 8:87-96 (1990).
Robins, Biochem. J. 207:617-620 (1982).
Ishikawa and Cimasoni, Archs Oral Biol. 15:1401-1404 (1970).
Giannobile William V.
Lynch Samuel E.
Williams Ray C.
Institute of Molecular Biology, Inc.
President and Fellows of Harvard College
Redding David A.
LandOfFree
Pyridinoline crosslinks as markers of periodontal and peri-impla does not yet have a rating. At this time, there are no reviews or comments for this patent.
If you have personal experience with Pyridinoline crosslinks as markers of periodontal and peri-impla, we encourage you to share that experience with our LandOfFree.com community. Your opinion is very important and Pyridinoline crosslinks as markers of periodontal and peri-impla will most certainly appreciate the feedback.
Profile ID: LFUS-PAI-O-1895246